Basilea Pharmaceutica — Zevtera hits the shelves in the US
Basilea Pharmaceutica has announced the launch of Zevtera, its lead anti-bacterial treatment, in the US by partner Innoviva Specialty Therapeutics...
242 Views
Basilea Pharmaceutica — Encouraging start to the year for Cresemba
Basilea Pharmaceutica has continued its strong momentum into 2025, announcing the receipt of a CHF1.2m milestone payment for Cresemba for the...
192 Views
Basilea Pharmaceutica — Another year, another market beat
Basilea recorded another strong year in FY24, its third successive year of cash flow positivity and its strongest operating performance to date....
140 Views
Basilea Pharmaceutica - Partner in place for US commercialisation of Zevtera
Following FDA approval in April 2024, Basilea has announced a much-anticipated partnership agreement with Innoviva Specialty Therapeutics for the...
324 Views
Basilea Pharmaceutica - Milestone march continues for Cresemba
Basilea Pharmaceutica has reported another US$1.25m milestone payment from its partner Pfizer in Asia-Pacific and China, triggered by Cresemba...
352 Views